2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors

2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors

The present invention provides a novel 2-pyridyl substituted imidazole derivative, or a pharmaceutically acceptable salt or solvate thereof, which selectively inhibits the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4); a pharmaceutical composit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lee, Hyun Jung, Ahn, Jaeseung, Shin, Dong Chul, Kim, Jae-Sun, Jung, Hoechul, Kim, Yong-Hyuk, Lee, Bong-yong, Lee, Ju Young, Kim, Hun-Taek, Ryu, Keun-Ho, Kang, Sang-hwan, Park, Euisun, Shin, Young Ah, Ryu, Je Ho
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides a novel 2-pyridyl substituted imidazole derivative, or a pharmaceutically acceptable salt or solvate thereof, which selectively inhibits the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4); a pharmaceutical composition comprising same as an active ingredient; and a use of the 2-pyridyl substituted imidazole derivative for the manufacture of a medicament for preventing or treating a disease mediated by ALK5 and/or ALK4 receptors in a mammal.